Cochrane Database of Systematic Reviews 2009
DOI: 10.1002/14651858.cd007893
|View full text |Cite
|
Sign up to set email alerts
|

Effect of cyclosporine on blood pressure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
45
2
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(49 citation statements)
references
References 3 publications
0
45
2
2
Order By: Relevance
“…12,13,21,22,31,40,43 The uniform use of tacrolimus rather than the more prohypertensive CNI, cyclosporine, may have also contributed to the excellent BP achieved in this population of kidney transplant recipients. 3,17,21,31,44,45 Our analysis did not show a difference in the effect of nebivolol and metoprolol on the renal function of kidney transplant recipients from baseline to the 12th month of the study. This is consistent with the relatively neutral physiologic effect of b-blockers on overall renal function.…”
Section: Discussioncontrasting
confidence: 49%
“…12,13,21,22,31,40,43 The uniform use of tacrolimus rather than the more prohypertensive CNI, cyclosporine, may have also contributed to the excellent BP achieved in this population of kidney transplant recipients. 3,17,21,31,44,45 Our analysis did not show a difference in the effect of nebivolol and metoprolol on the renal function of kidney transplant recipients from baseline to the 12th month of the study. This is consistent with the relatively neutral physiologic effect of b-blockers on overall renal function.…”
Section: Discussioncontrasting
confidence: 49%
“…21 Thus, treating hypertension with a drug that increases CsA blood levels may consequently enhance hypertension and would thus not be suitable. 1 The identification of the safest CCB regarding potential drug-drug interactions with CsA is desirable in HSCT children.…”
Section: Resultsmentioning
confidence: 99%
“…A recent systematic review regarding the effect of CsA on BP has shown an average increase of 5 mmHg with lower doses (1-4 mg/kg per day) of CsA, while the duration of the study was 2 years or less. 25 The course of hypertension is unclear in patients receiving long-term CsA treatment. Careful monitoring of BP is necessary in these patients.…”
Section: Discussionmentioning
confidence: 99%